To assess the effect of nonsurgical management of leiomyomas, abnormal uterine bleeding, and chronic pelvic pain on symptoms and quality of life.
We performed a prospective cohort study of women receiving nonsurgical management (n=380) or hysterectomy (n=311) for leiomyomas, abnormal uterine bleeding, or chronic pelvic pain.
Patients recruited from the practices of 63 physicians throughout Maine were interviewed at the outset of treatment and 3, 6, and 12 months later.
The principal outcome measures were frequency and severity of physical and psychological symptoms, and quality of life as measured by validated indices of mental and general health and physical activity.
Mots-clés Pascal : Femelle, Homme, Traitement, Chimiothérapie, Léiomyome, Utérus, Algie pelvienne, Métrorragie, Qualité vie, Pronostic, Etats Unis, Appareil génital femelle pathologie, Amérique du Nord, Amérique, Utérus pathologie, Tumeur bénigne
Mots-clés Pascal anglais : Female, Human, Treatment, Chemotherapy, Leiomyoma, Uterus, Pelvic pain, Metrorrhagia, Quality of life, Prognosis, United States, Female genital diseases, North America, America, Uterine diseases, Benign neoplasm
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 94-0374993
Code Inist : 002B30A03B. Création : 199406.